Company profile: Synformulas
1.1 - Company Overview
Company description
- Provider of probiotic medical devices, dietary supplements, and products for a balanced diet focused on gastrointestinal and vaginal health. Offers Kijimea Reizdarm PRO for irritable bowel syndrome (B. bifidum HI-MIMBb75), Kijimea K53 and K53 Advance with multiple bacterial strains plus vitamin B12/biotin, Kijimea Regularis and Regularis PLUS for constipation/bloating, and Kijimea FloraCare with Lactobacillus strains and vitamins.
Products and services
- Kijimea FloraCare: A multi-strain product featuring Lactobacillus strains and vitamins that supports the vaginal microbiome and mucosa, engineered to reinforce microbial balance and epithelial health
- Kijimea K53: A 53-strain dietary supplement with vitamin B12 that reduces fatigue and supports the nervous system through targeted microbial diversity
- Kijimea K53 Advance: A high-dosage enhancement of Kijimea K53 with increased bacterial strain load and biotin, architected to maintain mucous membranes for enhanced mucosal integrity and sustained microbiome support
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Synformulas
Groupe Berkem
HQ: France
Website
- Description: Provider of plant extracts and chemical formulations, supplying plant-origin cosmetic ingredients and anti-aging active ingredients such as grape seed undecylenate, vectorized polyphenols, a cosmetic formulation guide, Pineol (French maritime pine bark extract), Vitisol (grape seed extract), and grape seed extract.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Groupe Berkem company profile →
Uqora
HQ: United States
Website
- Description: Provider of urinary tract health support products, offering a Complete Regimen: Flush, a D-Mannose and Vitamin C drink mix to help flush the urinary tract; Defend, capsules to cleanse biofilm and support bladder wall integrity with Turmeric Root Extract and Vitamin D3; and Promote, a vaginal probiotic with Lactobacillus to support vaginal health linked to urinary tract health.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Uqora company profile →
NutriLeads
HQ: The Netherlands
Website
- Description: Provider of plant-based precision prebiotic fibers and nutritional ingredients with demonstrated health effects. Partners with food industry companies to identify promising lead ingredients and develop sustainable, commercially viable production processes. Offers Benicaros, a precision prebiotic fiber from upcycled carrot pomace designed to enhance immune responses and improve gut microbiota composition.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NutriLeads company profile →
Noblegen
HQ: Canada
Website
- Description: Provider of nutritional and functional plant-based food and ingredients using cell-to-solution technology. Offerings span protein, lipids and carbohydrates (beta-glucan) and functionality; all ingredients are non-GMO, certified vegan and minimally processed. Products include a plant-based egg, snackable protein crisps and snack bars.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Noblegen company profile →
Kappa Bioscience
HQ: Norway
Website
- Description: Provider of high-purity vitamin K2 (MK-7) ingredients, pioneering the synthetic, biologically active all-trans MK-7 marketed as K2VITAL, offered in tablets, softgels, powders, and liquids. Offers K2VITAL DELTA microencapsulated for mineral-stable formulations; custom organic synthesis, analytical services, and API production; product development and consultancy; and promotional content and film services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Kappa Bioscience company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Synformulas
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Synformulas
2.2 - Growth funds investing in similar companies to Synformulas
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Synformulas
4.2 - Public trading comparable groups for Synformulas
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →